Here comes: Press-Releases
Press-Releases
June 13, 04:18 (America New York)
CGTN: China to build Zhejiang into demonstration zone for common prosperity
PR Newswire:
June 12, 22:00 (America New York)
Marcus Ericsson, Honda Win Opening Round of Detroit Doubleheader
PR Newswire:
June 12, 18:50 (America New York)
Inauguration of the PowerLook Franchise in Manaus is a success
PR Newswire:
June 12, 16:34 (America New York)
Inauguration of the PowerLook Franchise in Manaus is a success
PR Newswire:
June 12, 15:40 (America New York)
The packages sent by Colombians from abroad are threatened
PR Newswire:
June 12, 14:44 (America New York)
At SNEC 2021, Risen Energy presented the first mass-produced 700 W high-efficiency NewT @ N power supply module
PR Newswire:
June 12, 14:38 (America New York)
Risen Energy Introduces NewT @ N High Efficiency 700W Power Module at SNEC 2021
PR Newswire:
June 12, 14:08 (America New York)
Huawei Digital Power wants to build a competent global partner community for a green and bright future
PR Newswire:
June 12, 14:02 (America New York)
Huawei Digital Power is committed to building a full-fledged global partner community
PR Newswire:
June 12, 13:51 (America New York)
Freshpet Voluntarily Recalls One Lot of Freshpet:registered: Select Small Dog Bite Size Beef ＆ Egg Recipe Dog Food Due to Potential Salmonella Contamination
PR Newswire:
June 12, 13:38 (America New York)
Alzheimer’s Association Statement: Next Steps For New Alzheimer’s Treatment
PR Newswire:
June 12, 13:23 (America New York)
CGTN: Former French Prime Minister Highlights Innovative Ideas in Chinese Leader's Book
PR Newswire:
June 12, 13:05 (America New York)
CGTN: What is behind the great aspirations of the Chinese youth?
PR Newswire:
June 12, 13:00 (America New York)
SKT to Participate in E3 2021 to Showcase Exciting Korean Games
PR Newswire:
June 12, 12:52 (America New York)
CGTN: What is behind young Chinese people’s lofty ambitions?
PR Newswire:
June 12, 10:00 (America New York)
Jimmy Mistry Launches Della Leaders Club, World’s First Business Platform, Helping Leaders Evolve from a Life of Success to A Life of Significance
PR Newswire:
June 12, 09:34 (America New York)
HARMONY presents new findings in chronic lymphocytic leukemia (CLL) at the EHA2021 Virtual Congress
PR Newswire:
June 12, 09:31 (America New York)
HARMONY Presents New Data on Chronic Lymphocytic Leukemia (CLL) at EHA2021 Virtual Congress
PR Newswire:
June 12, 09:16 (America New York)
Rick Barnett is Recognized As NACD Directorship Certified:trade_mark:
PR Newswire:
June 12, 09:04 (America New York)
Sustained growth in production even during the pandemic: VVDN announces measures
PR Newswire:
June 12, 09:01 (America New York)
VVDN announces action as manufacturing industry growth continues despite pandemic
PR Newswire:
June 12, 07:31 (America New York)
Did You Acquire (QS) Before November 27, 2020? Johnson Fistel Investigates QuantumScape; Should Management be Held Accountable for Investors Losses?
PR Newswire:
June 12, 07:05 (America New York)
China to deepen reform, opening-up, expand cooperation in new era
PR Newswire:
June 12, 07:02 (America New York)
IMBRUVICA:registered: (ibrutinib) Plus VENCLEXTA:registered:/VENCLYXTO:registered: (venetoclax) Combination Shows Superior Progression-Free Survival Compared to Chlorambucil Plus Obinutuzumab in First-line Chronic Lymphocytic Leukemia (CLL) Phase 3 GLOW Study
PR Newswire:
June 12, 07:00 (America New York)
Janssen Announces Results from Phase 3 MAIA Study Showing Significant Overall Survival Benefits for Treatment with DARZALEX:registered: (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant Ineligible
PR Newswire:
June 12, 07:00 (America New York)
New Phase 3 Study Results Show IMBRUVICA:registered: (ibrutinib)-Based Combination Regimen as an All-Oral Fixed-Duration Treatment Demonstrated Superior Progression-Free Survival in Adult Patients with Previously Untreated Chronic Lymphocytic Leukemia
PR Newswire:
June 12, 06:42 (America New York)
Looking for answers: An American communist explores China
PR Newswire:
June 12, 06:04 (America New York)
Expert: Tariff warfare against China is futile
PR Newswire:
June 12, 04:20 (America New York)
Perfect World to pioneer digital culture and creative sector in joint hands with partners
PR Newswire:
June 12, 03:26 (America New York)
Daiki Axis Co., Ltd. (4245, First Section, Tokyo Stock Exchange) Overview of Operating Performance for the First Three Months Ended March 31, 2021
PR Newswire:
June 12, 03:00 (America New York)
European Hematology Association: Humoral response to Pfizer / BioNTech BNT162b2 vaccine is impaired in patients receiving CAR-T or high-intensity immunosuppressive therapy
PR Newswire:
June 12, 03:00 (America New York)
European Hematology Association (EHA) - Administration of daratumumab improves progression-free survival after autologous stem cell transplantation in patients with multiple myeloma
PR Newswire:
June 12, 03:00 (America New York)
European Hematology Association - The first-line Ibrutinib + Venetoclax combination is more effective than the Chlorambucil + Obinutuzumab combination for the treatment of chronic lymphocytic leukemia and small lymphocyte lymphoma
PR Newswire:
June 12, 03:00 (America New York)
European Hematology Association: Overall survival benefit established with daratumumab plus lenalidomide and dexamethasone (D-Rd) in elderly patients with newly diagnosed multiple myeloma (NDMM) not eligible for transplant
PR Newswire:
June 12, 03:00 (America New York)
European Hematology Association: Ibrutinib + venetoclax as initial treatment for chronic lymphocytic leukemia / small cell lymphocytic lymphoma works better than chlorambucil + obinutuzumab
PR Newswire:
June 12, 03:00 (America New York)
European Hematology Association: Overall Survival Benefit Established With Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) in Elderly Patients with Transplant-ineligible Newly Diagnosed Multiple Myeloma (NDMM): Long-Term Interim Analysis of the MAI
PR Newswire:
June 12, 03:00 (America New York)
EHA: Efficacy of the Pfizer / BioNTech BNT162b2 vaccine in patients receiving CAR-T
PR Newswire:
June 12, 03:00 (America New York)
European Association of Hematology (AEH) - Pegcetacoplan maintains a sustainable response in patients with paroxysmal nocturnal hemoglobinuria at week 48
PR Newswire:
June 12, 03:00 (America New York)
European Hematology Association - Pegcetacoplan shows sustained response in patients with paroxysmal nocturnal hemoglobinuria through week 48
PR Newswire:
June 12, 03:00 (America New York)